PAGE LAB BIOMEDICS
Contact ▸
Company Clinical Expertise HSEF™ ISO9™ Partnership

CLINICAL-DRIVEN BIOMEDICAL R&D

Clinical insight, engineered into new standards.

PAGE LAB BIOMEDICS turns problems found in real-world aesthetic practice into research questions, proprietary formulation technology and finished products built for professional use.

HSEF™ is our proprietary formulation technology for the environment post-procedure skin meets; ISO9™ is the brand we build with it.

CLINICAL INSIGHT → HSEF™ TECHNOLOGY → ISO9™ PRODUCTS

THE GAP

Dermocosmetics are everywhere. A clear post-procedure choice is not.

A dermocosmetic label does not automatically tell a clinician how a finished product will behave on freshly treated skin. Formulation, pH, osmolality, fragrance and preservative systems, acids and surfactants all differ from product to product.

The category exists. What is still missing is a widely adopted, practical finished-product framework designed to help clinicians and consumers evaluate skincare for immediate post-procedure use.

When product suitability is uncertain, clinicians may take the more conservative route — limiting what is applied immediately after a procedure.

When the safest choice is “less,” the category has a design problem.

Why we developed HSEF™ ▸
FIG. 01 — WHERE THE TWO DO NOT MEET

COSMETIC SCIENCE

Ingredients

Efficacy

Sensory

Stability

AESTHETIC MEDICINE

Procedures

Treatment response

Post-procedure condition

Clinical tolerability

What should touch the skin immediately after a procedure?

THE CLINICAL QUESTION

Post-procedure skin is different.

FIG. 01 — THE DESIGN OBJECT: THE EXTERNAL AQUEOUS ENVIRONMENT THE SKIN MEETS

Immediately after an aesthetic procedure, the skin may temporarily experience altered barrier function and increased sensitivity.

In this condition, skincare should not be considered only in terms of active ingredients. The physicochemical environment directly contacting the skin — osmolality, pH, ionic composition and known sources of irritation — also deserves consideration.

PAGE LAB BIOMEDICS therefore approaches the aqueous environment that post-procedure skin encounters as an engineering variable in its own right.

This question became the starting point for HSEF Buffer™.

HOW THE COMPANY IS BUILT

01

Clinical Expertise

WHERE QUESTIONS BEGIN

Clinicians and clinical anatomists whose practice defines the problems we choose to research.

EXPLORE ▸

02

HSEF™

PROPRIETARY FORMULATION TECHNOLOGY

Osmolality, electrolytes, skin-adapted pH and buffering, designed at the level of the finished product.

EXPLORE ▸

03

ISO9™

PROPRIETARY POST-PROCEDURE SKINCARE

Our own brand, developed on HSEF™ technology under defined product principles.

DISCOVER ▸

Clinical insight becomes formulation science. Formulation science becomes ISO9™.

OUR DEVELOPMENT MODEL

From clinic to standard.

Our development process begins where the technology will ultimately be used: in clinical practice.

Clinical observations are translated into measurable design criteria, evaluated at the finished-product level and refined through real-world validation.

01

CLINICAL OBSERVATION

Identify unmet needs and recurring problems in real-world aesthetic practice.

02

SPECIFICATION DESIGN

Translate clinical observations into measurable physicochemical and formulation criteria.

03

FORMULATION & SCREENING

Develop and evaluate formulations at the finished-product level against predefined specifications and exclusion criteria.

04

CLINICAL VALIDATION

Evaluate fitness for use under real clinical conditions and refine the standard through accumulated data.

A closed loop between clinical practice, research and product development.

Explore Clinical Expertise ▸

CONTENTS

01 Company Who we are, and how research, clinic and brand close the loop. 02 Clinical Expertise Clinicians and clinical anatomists who contribute to research, development and validation. 03 HSEF™ Our proprietary formulation technology for the environment post-procedure skin meets. 04 ISO9™ Our proprietary post-procedure skincare brand, built on HSEF™ technology. 05 Partnership Strategic R&D, co-development and clinical collaboration.

Build the next clinical standard with us.

STRATEGIC R&D · CO-DEVELOPMENT · TECHNOLOGY · CLINICAL EVIDENCE

Explore collaboration ▸